What is the ticker symbol for Novo Nordisk A/S?

Novo Nordisk A/S trades under the ticker NVO on NYSE.

What sector does Novo Nordisk A/S operate in?

Novo Nordisk A/S is classified in the Health Care sector (Pharmaceuticals industry).

How can PortView help analyze NVO in a portfolio?

PortView shows NVO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Novo Nordisk A/S (NVO) Stock Analysis

NYSEHealth CarePharmaceuticals

$46.60+3.28%

1-year price historyRange $35.29 – $63.98

52-week range$46.60

$35.12$64.16

What Novo Nordisk A/S does

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Key metrics

Market cap

$206.93B

P/E (TTM)

11.59

EPS (TTM)

$4.02

Beta

0.35

Dividend yield

2.49%

Revenue / share

$74.40

50-day avg

$47.92

200-day avg

$46.37

52-week high

$64.16

52-week low

$35.12

CEO

Maziar Mike Doustdar

ETFs linked to NVO

Broad-market and Health Care sector ETFs an investor holding Novo Nordisk A/S is often also exposed to. Open an ETF page to see its actual top holdings.

XLV — Health Care Select Sector SPDR VHT — Vanguard Health Care ETF SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF

PortView Portfolio Insights

PortView analyzes how NVO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NVO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Novo Nordisk A/S?: Novo Nordisk A/S trades under the ticker NVO on NYSE.
Which exchange is NVO listed on?: NVO is listed on NYSE.
What sector does Novo Nordisk A/S operate in?: Novo Nordisk A/S is classified in the Health Care sector (Pharmaceuticals industry).
How can PortView help analyze NVO in a portfolio?: PortView shows NVO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.